SS
Insider
Shehnaaz Suliman
DirectorShehnaaz Suliman (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in 10x Genomics, Inc. (TXG). The largest single filing was $175K of TXG (5,359 sh × $32.59, as filed), executed Jun 16.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$424K
shares × price, as filed
Last traded
Aug 24
Filed Aug 26
Median ADV $190.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $424K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
TXGRecent filings
TXGSALE
10x Genomics, Inc.
View filing →
$105K1,646 sh × $63.97
Exec Aug 24
Filed Aug 26 · 4:42 PM ET TXGSALE 10x Genomics, Inc. View filing → $175K
5,359 sh × $32.59
Exec Jun 16
Filed Jun 18 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $144K
5,740 sh × $25.12
Exec May 18
Filed May 18 · 5:30 PM ET